Genetic testing for cardiomyopathies-when science and health policies join in personalizing cardiovascular prevention

Ruxandra Jurcut^{1

2}, Bogdana Fetecău^{1

2}

Affiliations

¹ Expert Center for Rare Cardiac Genetic Diseases, Emergency Institute for Cardiovascular Diseases 'Prof.dr.C.C.Iliescu', Bucharest, Romania.
² Department of Cardiology, University of Medicine and Pharmacy 'Carol Davila', BucharestRomania.

Editorial

Ruxandra Jurcut et al. Eur J Prev Cardiol. 2022.

. 2022 Oct 18;29(13):1785-1788.

doi: 10.1093/eurjpc/zwac160.

Ruxandra Jurcut^{1

2}, Bogdana Fetecău^{1

2}

¹ Expert Center for Rare Cardiac Genetic Diseases, Emergency Institute for Cardiovascular Diseases 'Prof.dr.C.C.Iliescu', Bucharest, Romania.
² Department of Cardiology, University of Medicine and Pharmacy 'Carol Davila', BucharestRomania.

No abstract available

Conflict of interest statement

Conflict of interest: None declared.

Molecular genetics in 4408 cardiomyopathy probands and 3008 relatives in Norway: 17 years of genetic testing in a national laboratory.
Stava TT, Leren TP, Bogsrud MP. Stava TT, et al. Eur J Prev Cardiol. 2022 Oct 18;29(13):1789-1799. doi: 10.1093/eurjpc/zwac102. Eur J Prev Cardiol. 2022. PMID: 35653365